JPRN-UMIN000005726已完成未知
Comparison of add-on treatment with Aliskiren versus Diuretics to angiotensin II receptor blocker based Therapy - Aliskiren Evaluation on Augmentation Index (ALEA) study
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical SciencesDepartment of Cardiovascular Medicine0 个研究点目标入组 140 人开始时间: 2012年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1, Secondary hypertension 2, Severe hypertension(SBP 200mmHg or more or DBP 115mmHg or more) 3, Congestive heart failure 4, Severe valvular disease 5, Myocardial infarction or acute period of cerebrovascular disease(within 6 months) 6, Atrial fibrillation(paroxysmal,stained,chronic) 7, Malignant ventricular arrhythmia 8, Renal insufficiency(Serum creatinine 2mg/dL or more) 9, Severe Liver Dysfunction 10, Chronic inflammatory disease 11, The patient with a malignant tumor 12, Patients who are determined by the investigators to be unsuitable
研究者
相似试验
已完成
4 期
Comparison of effects of aliskiren-based combination therapy between CCB and ARB in hypertensive patients with chronic kidney diseaseHypertension, chronic kidney diseaseJPRN-UMIN000006821Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine100
已完成
不适用
Efficacy and Safety of Valsartan and Aliskiren Combination Therapy in Patients with Diabetic Nephropathy and HypertensioType 2 diabetes with nephropathy and hypertensionJPRN-UMIN000003741Kansai Medical University80
已完成
3 期
Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE)Myocardial InfarctionNCT00414609Novartis820
已完成
3 期
A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of AmlodipineHypertensionNCT00219154Novartis1,125
进行中（未招募）
不适用
Estudio de los efectos de ALiskiren o Losartán sobre los bioMARKadores del remodelado miocárdico. Estudio ALLMARK - ALLMARKHIPERTENSIÓN ARTERIAL ESENCIAL Y HIPERTROFIA VENTRICULAR IZQUIERDAEUCTR2009-016735-36-ESovartis Farmacéutica S.A.